STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; Schreiber, N. A.; Curtis, K. R.; Maslyar, D. J.; Lemahieu, V.; Fine, B. M.; Mamounas, M. J.; Ungewickell, A. J.; Lackner, M. R.; Scher, H. I.; Kabbarah, O. |
| Abstract Title: | STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC) |
| Meeting Title: | 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901071 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.5029 |
| Notes: | Meeting Abstract: 5029 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
